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Microbiology

Cloning and Characterization of a Gene Encoding Proteins Associated with the
Bacteriophage-like Particle o f Bartonella bacilliformis
Chair: Michael F. Minnick, Ph.D.

-----

Bartonella bacilliformis, the etiologic agent o f Oroya fever, has been shown to
package 14-kbp DNA fragments of host chromosome into bacteriophage-like
particles (BLPs). These BLPs were isolated and purified using chloroform, DNase I,
and ultracentifiigation. Polyclonal antiserum was raised against BLPs in a New
Zealand white rabbit, and seroreactivity was tested on a whole cell lysate o f B.
bacilliformis screened with the antiserum. A IZ A P II genomic library o f B.
bacilliformis DNA was screened with collected antiserum, and multiple rounds of
plaque purification were done to isolate recombinant clones. The DNA insert o f
interest was recovered from the library as a recombinant phagemid, termed pLC 1, and
used to infect the XLOLR strain ofE. coli. The size o f the insert in pLCl was
determined to be approx. 2,800 bp, and the sequence o f the insert was determined at
the Murdock Molecular Facility. Multiple BLAST searches o f the sequenced insert
revealed genes encoding homologues o f three translational machinery proteins found
in other bacteria, including elongation fector TS (tsf), ribosome recycling fector {frr),
and uridylate kinase {pyrH). The E.coli XL-1 Blue containing the pLCl was foimd to
synthesize a protein o f 39 kDa in size. While the insert did not contain nucleotide
sequences encoding the 32, 34, or 36 kDa capsid proteins initially sought, this work
nonetheless characterized three novel genes o f the pathogen that are essential to
translation.
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Chapter I
Introduction
Bartonella bacilliformis is a Gram negative, hemotrophic bacterium (1) that
is roughly 0.25 to 0.50 pm in width and 1.0 to 3.0 pm in length. B. bacilliformis
parasitizes human erythrocytes and endothelial cells (2, 3). Transmission o f the
pathogen to humans occurs through the bite o f the phlebotomus sand fly (9), a vector
present only in high altitudes of the Andes regions of Colombia, Peru, and Ecuador
(1). B. bacilliformis is the etiologic agent o f Oroya fever (Carrion’s disease) (4); a
disease that exhibits two unique forms. The primary form is characterized by
infection o f nearly all circulating erythrocytes. Resulting symptoms include a severe
hemolytic anemia, along with fever, malaise and skin pallor (2). Lysis o f almost 80%
o f the circulating erythrocytes is not uncommon (5). Mortality rates associated with
this phase are nearly 40% without the administration o f proper antimicrobials (1,6).
Progression o f the disease into the secondary (tissue) phase involves invasion of
vascular endothelial cells and commonly manifests 1-2 months after the initial
infection. The presence o f cutaneous hemangiomas (termed verruga peruana by the
natives) on the face and extremities is characteristic o f the tissue phase, and is a
direct result o f the bacterium invading the vasculature (7). Hepatosplenomegaly,
lymphadenopathy, and severe immuno suppression are additional complications
frequently encountered (8). In addition, masses o f bartonellae can fill the cytoplasm
of host cells lining the blood vessels, leading to endothelial swelling and thrombosis
(42). The verruga stage is rarely fetal and will resolve over time. Investigation into

the pathogenic mechanisms and virulence fectors instrumental in B. bacilliformis
invasion o f erythrocytes and endothelial cells is currently underway (2, 3, 33, 35, 36).
For over 80 years, B. bacilliformis was the only known member in the genus
Bartonella (10). Recent advances in molecular biology have shown that the 16S
rRNA sequences o f Rochalimaea and Grahamella are homologous to B.
bacilliformis (11, 12). Thus, a taxonomic reclassification was done to include these
members. In addition, several novel species have since been added, the most recent
beii^ B. clarridgeiae (13).
Among the 14 species of Bartonella currently recognized, five are known to
be pathogenic to humans, and are the causative agents o f several emerging diseases
(14, 37, 38, 39). Two examples, B. henselae and B. bacilliformis, are unique in that
they produce bacteriophage-like particles (BLPs) (15). Previous electron
microscopy studies revealed the presence of round to icosahedral extracellular
particles o f 80 run in diameter associated with the outer surface of B. bacilliformis
and B. henselae (15, 16). These particles package near-random, 14-kbp Bartonella
genomic DNA fi-agments (15). The double-stranded extrachromosomal elements are
well-protected from chloroform/DNase I treatment by the external capsid proteins
(15, 18). Bacteriophage-like particles are similar but not identical to true
bacteriophages in that they package host DNA into pre-formed capsid heads, but
apparently contain no obvious genetic material from the phage (15).
BLPs are not unique to certain species o f Bartonella. Several other unrelated
bacteria have been found to possess them (19,21). The PBSX phage o f Bacillus
subtilis (30), and the VSH-1 phage o f Serpulina hyodysenteriae (31) are prime

examples, and the latter has been shown to undergo generalized transduction.
Rhodobacter capsulatus, a purple non-sulfur bacterium, utilizes a small
bacteriophage-like particle (GTA) that packages random 4.5-kbp fragments o f the
host cell’s genome and transfers it to a recipient cell (40). With the presence o f these
BLPs across a broad range o f different bacterial species, one could assume they share
some common functions. Horizontal gene transfer o f virulence determinants is one
mechanism contributing to the development of emerging infections (14), and some
BLPs are thought to aid in this process via transduction ( 18).
Bacteria can exchange DNA by utilizing three possible mechanisms including
transduction, transformation, and conjugation (34). During bacterial transduction,
bacterial DNA is abnormally encapsidated into a bacteriophage and transferred to a
recipient cell. These phage particles are composed o f a core of nucleic acid
surrounded by a protein coat. A phage capable of infecting bacterial cells binds to a
receptor site on the host cell. A phage enzyme then weakens the host cell wall,
allowing the viral nucleic acid to be “injected” into the host. After penetration of
viral DNA, one o f two possibilities can occur, depending on whether the phage is
temperate or lytic (41).
Lytic phages are en able of causing the destruction and death o f a bacterial
cell. Once viral nucleic acid has entered the host bacterium, the phage genes direct
the host’s machinery to synthesize phage proteins and nucleic acids. Some o f these
proteins may degrade the host cell DNA, while others are structural components o f
future phages. Eventually, the intracellular viral titer reaches a critical point, and

specific enzymes are released from the phages, causing destruction o f the bacterial
cell in a process termed lysis. These new progeny phage can now infect other cells.
The temperate phage utilizes a different mechanism. Instead o f lysing the host cell, a
temperate phage will undergo a stage analogous to transposition, whereby its nucleic
acid integrates into the genome of the host bacterial cell This unique characteristic
o f ten^)erate phages allows it to reproduce along with the host DNA. This
quiescent phage nucleic acid insert is referred to as a prophage. Temperate phages
can replicate as a p ro p h ^ e in a bacterial chromosome. Temperate phages are able to
undergo two forms o f transduction: generalized and specialized.
Specialized transduction occurs when a certain gene or group o f genes is
transferred via the bacteriophage to another bacterium. Specifically, the prophage
nucleic acid is incorrectly excised from the host chromosome, allowing a portion of
the bacterial DNA to be carried along with it. Thus, subsequent packaging o f this
novel host DNA occurs, allowing some portion of the bacterial DNA to be included
in the bacteriophage particle. Generalized transduction occurs when non-specific
portions o f the bacterial chromosome are incorporated into phage heads in place of
phage DNA. Some phage enzymes are able to degrade host DNA into small
fragments. Since headfiil packaging is usually a random event (although previous
studies with B. bacilliformis have shown the specificity to be much less random than
previously thought) (16), random pieces o f host DNA are incorporated into the
capsid head. In some cases, the phage DNA is replaced almost entirely by host
DNA. These “defective” phages can now attach to another bacterial cell and inject
the packaged host DNA into the new bacterial cell. Homologous recombination and

allelic exchange between the transduced DNA and host bacterial chromosome can
now occur, leading to alteration o f the bacterial chromosome of the recipient.
Transfer o f antibiotic resistance genes is one possibility that can have a dramatic
effect on the viability o f the recipient bacterium. To date, transfer o f genetic material
via other methods such as transformation and conjugation have not been
demonstrated in the Bartonella genus (22). While it was hypothesized that B.
bacilliformis BLPs participate in intraspecies horizontal gene transfer via
transduction-mediated genetic exchange, previous research was unable to definitively
demonstrate this activity (16). Research on the structure of the BLPs oiB.
bacilliformis has revealed the presence of three major proteins in the capsid coat
with molecular weights o f 32, 34, and 36 kDa (16). The nucleotide sequences for
these genes has not been elucidated to date.
Due to its nature as an emerging pathogen with newly classified species and
subspecies, the genus Bartonella is a constant threat to human and other mammalian
hosts. While Oroya fever was once thought to be contained within a narrow location
around 10,000 ft, recent evidence has shown an increase in cases affecting coastal
populations at the base o f the Andes (43). In addition, the fi-equency o f international
travel gives this isolated pathogen more opportunity to spread to non-endemic areas.
Thus, the mechanisms o f invasion and genetic transfer of this bacterium must be
studied in detail.
While the initial purpose of this research was to identify the nucleic acid
sequences encoding at least one of the 32, 34, or 36 kDa proteins of the BLP capsid,
genomic library screening with anti-BLP antibodies resulted in recovery o f a plasmid

containing DNA sequences coding for three translational machinery proteins o f the
host. These encoded proteins were identified via homology using a BLAST search,
and include Uridylate kinase, Elongation fector TS, and Ribosome recycling fector.

Chapter II
Materials and Methods

A. Growth of bacterial strains
The primary B. bacilliformis strain used in this study was JB585, a flagellin'
{fid) mutant, kan ^(Battisti and Minnick, 1999) grown on heart infiision agar plates
supplemented with 4% defibrinated sheep erythrocytes (v/v) and 2% filter-sterilized
sheep serum (v/v) (Quad Five, Ryegate, MT). Cultures were incubated at 30°C for 4
to 5 days at 5% CO2 . The major antibiotic used in this study was kanamycin (25
pg/ml). All E. coli strains required for propagation o f cloned genes were grown
overnight at 37°C in Luria-Bertani medium containing kanamycin (25 p,g/ml) (Sigma
Chemical Co., St. Louis, MO) when required (25).

B. Purification of BLPs
Forty plates o f B. bacilliformis were grown as above, and harvested into 15
ml SM phage buffer (28). Chloroform treatment (3% vol/vol) was then employed to
lyse the bacterial cells. This was followed by centrifugation at 6,000 x g for 5 min to
remove cellular debris. Removal o f any remaining viable bacteria was done by
collecting supernatant, chloroform treating as before, and centrifuging a second time.
DNase I was added to the resultant supernatant at a final concentration o f 2 ng/ml,
and incubated at 37°C for 2 h. After digestion o f chromosomal DNA BLPs were

pelleted via ultracentrifugation at 100,000 x g for 2 h using a SW60 rotor, model
1040 (Beckman, Palo Alto, California). The supernatant was decanted, and
remaining pellets were resuspended in 150 |il o f fresh SM buffer. BLP preparations
were stored at 4®C until needed.

C. SDS-Page AnalysisAVestern Blotting
Proteins from the BLP preparations were visualized using SDSpolyacrylamide gels (12.5% acrylamide) by the methods from Laemmli (29). Gels
were stained with Coomassie brilliant blue (0.05%) for visualization o f protein bands.
Immunoblotting was accomplished by first transferring the separated proteins from
the acrylamide gel to a nitrocellulose membrane (26). Membranes were dried, then
blocked in 0.3% Tween-20 and 2% non-fat skim milk in IX phosphate-buffered
saline (PBS) at pH 7.4 for 1 h at 25°C. Membranes were then rinsed in IX PBS, and
incubated overnight with polyclonal antiserum raised against the 32, 34, and 36 kDa
BLP proteins. Incubation with a secondaiy antibody (horseradish peroxidase-goat
anti-rabbit IgO) was then done for 1 h. Development was accomplished using IX
PBS, H2 O2 , 4-chloro-1-napthol, and methanol.

D. Inoculation of rabbit
The 32, 34, and 36-kDa capsid proteins in the BLP preparation were verified
by SDS-PAGE analysis. Protein concentrations were measured using a bicinchoninic
assay kit (Sigma Chemical, St. Louis, Mo.) and spectrophotometric analysis at 562
nm. A 4 ml pre-inoculation sample of rabbit blood was obtained prior to injection.

1)

Harvest B. hacilîiformis from HIBB into SM phage buffer (Approx. 0.5 ml

buffer/plate).
2)

Add CHCb to a final concentration o f 3% (v/v).

3)

Centrifiige at 4,000 x g for 5 minutes to remove cellular debris.

4)

Repeat step 3).

5)

Incubate the resulting supernatant with DNase I (2 pg/ml) for 2 h at 37°C.

6)

Centrifuge at 100,000 x g for 2 h at 37°C.

7)

Discard the supernatant and resuspend the pellet inSM phage buffer.

8)

Store at 4°C for up to 2 weeks.

Fig 1 Flowchart illustrating the protocol used for the purification o f BLPs from B.
bacilliformis.

A vaccine consisting of 1.5 ml Complete Freund’s Adjuvant (CFA) (Sigma),
1.4 ml IX phosphate-buffered saline (0.01 M phosphate, 0.15 M NaCl) (150 pi lOX
PBS, 1.35 ml DIH 2 O), and 0.1 ml BLP (0.61 mg/ml) was injected into a rabbit at 3
subcutaneous depots above the shoulders. The rabbit was then boosted after one
month with Incomplete Freund’s Adjuvant (IFA) (Sigma), IX PBS, and BLP as
above. Generated antiserum was then collected in 1Occ volumes for 2 weeks after
the booster.

£ . Genomic Library Screening
A previously-constructed B. bacilliformis ZAP Express II genomic library
was screened with the rabbit anti-BLP antiserum. Nitrocellulose circles were laid
over infected lawns o f E. coli, removed and incubated overnight with rabbit anti-BLP
antiserum. Positive plaques were identified through successive rounds o f plaque
purification.
Library Titer:
The host strain XL-1 Blue MRF’ was grown overnight from a frozen stock in
2 ml LB Mag/Mal (LB supplemented with 20 pi 20% maltose and 20 pi IM
magnesium sulfate) at 30®C with shaking at 200 RPM. Expansion was accomplished
by adding 0.5 ml o f the culture to 50 ml LB Mag/Mal. The culture was incubated for
2.5 h at 37°C with shaking at 200 RPM. The phage library was 10-foId serially
diluted in SM buffer. Each dilution (1 pi) was then added to 100 pi of the host strain
(XL-1 Blue). All samples were incubated in a 37®C water bath for 30 min. Overlays
were then prepared by melting 3 ml o f top agar in a tube and cooling to 55°C. The
10

phage/host mixture (100 pi) was added to the overlay, and poured over each LB
plate. Plates were allowed to harden for 10 min., incubated at 37°C overnight, then
counted the next day.
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Table 2.1 Table showing all vaccine injections and serum extractions listed with
dates and quantities.

Procedure

Amount

Type

Date

Pre-bleed

4 ml

Blood

5/17/00

1® injection

3 ml

CFA/JB585

5/17/00

2® injection

3 ml

IFA/JB585

6/14/00

1® serum col

12 ml

Blood

7/03/00

2® serum col

6 ml

Blood

7/11/00

3® serum col

10 ml

Blood

7/14/00

4® serum col

10 ml

Blood

8/09/00

4 ml

IFA/JB585

9/14/00

1® serum col

10 ml

Blood

9/30/00

2® serum col

12 ml

Blood

10/05/00

3® serum col

10ml

Blood

10/12/00

4® serum col

12 ml

Blood

10/24/00

Booster
(w/excised bands)
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Library screen
The phage library was diluted to 15,000 pfu per plate. The diluted
phage (1 pi) was added to 200 pi of host XL-1 Blue and incubated at 37°C for 4 hr.
Nitrocellulose disks were soaked briefly in 10 mM IPTG, and stored dry in empty
petri dishes until needed. Disks were then carefully laid onto agar overlays and the
plates incubated upside down at 37°C overnight. The next day, the plates were dried
for 30 min. at 37°C with lids open. The plates were then cooled by inversion at 4°C
for 30 min. Orientation o f the filters was recorded by marking distinct spots through
the circles into the agar using india ink and a probe. The nitrocellulose circles were
carefully pulled fi*om the agar using forceps and allowed to dry protein side up for 10
min. Probing with anti-BLP antisera was accomplished via the immunoblot protocol
described above.

F. Excision
Positive plaques identified fi’om the library were excised in vivo using E. coli
XLOLR and XL-1 Blue MRF’ strains, and rescued using the exassist helper phage
per manufacturer’s instructions (Stratagene). The resulting recombinant phagemids
were used to subsequently infect the XLOLR strain. Plaques that bound the primary
antibody were cored out o f the agar and transferred to a sterile microfuge tube
containing 500 pi SM buffer and 20 pi chloroform. The microfiige tube was then
vortexed in order to elute the phage particles. The tube was then incubated for 2 h a t
room temperature. Overnight cultures o f XL-1 Blue in LB Mag/Mal and XLOLR in
LB were prepared at 30®C. The following day, a 1:100 dilution of the overnight
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culture was prepared by adding 0.5 ml o f overnight culture to 50 ml LB. The culture
was then grown for 3 h at 37°C to mid-log phase. This was repeated for the XLOLR
strain. 200 pi o f the XL-1 Blue culture was then added to a 15 ml conical tube,
along with 100 pi o f phage stock, and 1 pi o f ExAssist helper phage. The contents
o f the tube were incubated in a 37°C hot water bath for 20 minutes. Three ml o f LB
media was added to the conical tube, followed by incubation for 2.5 hrs. at 37°C
with shaking at 200 RPM. The tube was then heated at 70°C for 15 min. and
centrifiiged for an additional 15 min. at 4,000 x g (7,000 RPM). The supernatant
was decanted into a sterile tube and stored at 4°C. Phagemids were then plated by
adding 200 pi o f XLOLR cells to two 1.5 ml tubes. 100 pi o f phage stock was
added to one tube, while 10 pi o f stock was added to the second tube. These tubes
were incubated at 37°C for 15 min. 300 pi of LB was added to each tube and
incubation was con^)leted at 37°C for 45 min. with no shaking. Finally, 100 pi from
each tube was plated on LB/Kan plates (50 pg/ml), and incubated overnight at 37°C.

G. M anipulation of DNA
Recovery o f pure plasmid DNA from E. coli was accomplished using a
Perfect Prep kit (EppendorQ. Protocol was followed as per manufacturer’s
instructions.
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H. Ligation of restricted DNA
All ligations were accon^lished by standard protocol. DNA (6 pi) at a
concentration o f 0.4 pg was added to a microfuge tube with 1 pi o f lOX ligation
salts (40 mM Tris-Cl, 10 mM MgCb). This mixture was heated at 65°C for 2
minutes. The mixture was then placed on ice, and 1 pi each of the following was
added: lOX DTT (10 mM), lOX ATP (0.5 mM), and T4 DNA ügase (1 “weiss”
U/pl). Following a quick “spin” at 14,000 RPM, the ligation was incubated at room
temperature for 2 hrs.

I. Transformation
A culture o f E. coli strain XL-1 Blue was grown overnight at 30°C with
shaking (200 RPM). This culture was then expanded the following day by
transferring 1 ml into an Erlenmeyer flask containing 20 ml LB. This mixture was
incubated for 2 hrs. at 37°C with 200 RPM shaking. The culture was then
centrifuged for 5 min. at 6,000 RPM. The supernatant was decanted, and the
resulting pellet was resuspended in 2 ml o f ice cold TSS (a chemical agent useful in
opening channels in the bacterium). Competent cells were then separated into 100 pi
aliquots in sterile Eppendorf tubes. 5 pi o f DNA o f interest (recovered insert) was
added to one aliquot. These preparations were then incubated on ice for 45 min.
Finally, 900 pi o f TSS was added to each aliquot, and samples were incubated for 75
min. at 37°C with shaking at 250 RPM. In order to achieve equal concentration of
the samples, the following procedure was used. Samples o f 500 pi, 250 pi, and 100
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were centrifuged in a tabletop centrifuge for 30 sec. at 14,000 RPM. The volume
o f the supernatant decanted was 400 pi, 150 pi, and 0 pi respectively. The resulting
pellet was then resuspended in the remaining volume (lOOpl). This volume of
bacterial culture was plated on LB/Kan25 plates, and incubated overnight at 37®C.

J. Nucleotide sequencing and analysis
Both strands o f DNA from the cloned DNA insert were sequenced at the
Murdock Molecular Biology Facility at the University o f Montana. T3 and T7 sites
on the pBK/CMV phagemid located outside the insert were used as initial primers for
the sequence reactions. Blast 2.0 was used for database searches for homologies,
and all sequence alignments were completed using FASTA (44), Clustal W 1.6 (45),
and BOXSHADE 3.21 (K. Hofrnann, and M.D. Baron,
hltD://w^u.ch.embnet.org/softwarc/BQX fonn.html.

1998).

K. Induction of E. coli XL-1 Blue cultures
All E. coli XL-1 Blue strains were grown overnight at 37°C, with shaking
(200 RPM) using a “seed” culture of 2 ml LB, and kanamycin to a concentration of
25 pg/ml. Cultures were then expanded on day 2 by adding 1.25 ml o f seed to 8.75
ml o f LB, and 21.9 pi o f Kanamycin stock (10 mg/ml). This preparation was grown
for 1 hr. at 37°C with shaking at 200 RPM. IPTG (10 mg/ml) was then added to
cultures at a final concentration o f 2 mM., and incubated for 2, 3, and 4 hrs each.
Cultures were then stored in 1 volume o f glycerol and frozen at - 80°C until needed.

16

Chapter III
Results

A. Purification o f BLPs in & bacilliformis
Figure 2 (next page) shows purified BLPs alongside a molecular weight
marker and a total cell lysate o f B. bacilliformis. The presence of the 32, 34, and 36
kDa bands in both the first and second lane clearly show that these proteins are
normally present in B. bacilliformis, and are major constituents o f the BLP.

B Generation o f antiserum against B, bacilliformis BLPs
Following recovery o f purified BLPs, the protein content was quantified via
bicinchoninic acid protein kit (Sigma Chemical, St. Louis, Mo.) plus
spectrophotometry at 562 nm. Data were graphically arranged using computer
analysis (QuatroPro for Windows). The quantified proteins were then added to a
vaccine preparation, as described previously, and injected into a New Zealand white
rabbit. All antiserum recovered fi*om the rabbit was tested for immunogenicity
against the 32, 34, and 36-kDa proteins in the B. bacilliformis BLP. Figure 3 shows
the corresponding immunoblot to Figure 2, and contains a molecular weight marker,
total protein profile for JB585, and the BLP preparation. Incubation with recovered
anti-BLP antibodies fi*om serum as primary antibody, followed by subsequent
development led to the observed pattern. The anti-BLP antibody probe recognized
the three bands corresponding to the 32, 34, and 36 kDa proteins in the total protein
profile and the BLP prep. This result indicates that the
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Fig 2. Coomassie brilliant blue-stained SDS PAGE gel (12.5% acrylamide)
showing B. bacilliformis JB585 whole-cell lysate and BLP associated proteins. Lane
1, B. bacilliformis JB585 whole-cell lysate showing a total protein profile; lane 2,
protein profile o f purified BLP proteins fi'om B. bacilliformis, showing the three
large bands at 32, 34, and 36 kDa (marked with >); lane 3, molecular mass standard
in kilodaltons.
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Fig 3. Corresponding Western blot to Figure 2. Blotted proteins were probed with
anti-BLP antiserum. Lane 1, 32, 34, and 36-kDa BLP capsid proteins (marked with
>) from B. bacilliformis JB585 whole-cell lysate; lane 2, protein profile of purified B.
bacilliformis BLPs showing the 32, 34, and 36-kDa major bands; lane 3, molecular
weight standards (rainbow) in kilodaltons.
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recovered antiserum from the rabbit is highly specific and immunoreactive with
respect to the three BLP proteins.

C.

Cloning the genes located on pLCl
A XZAP II B. bacilliformis genomic library was screened using the anti-BLP

antisera as the primary antibody probe, as described in materials and methods.
Several positive plaques were isolated and the purified, and recombinant PBK/CMV
plasmids were recovered from each E. coli clone. In addition, an SDS-PAGE gel
(Fig 4) shows several proteins from pLCl that are not found in the lane
corresponding to E. coli containing the control plasmid (PBK/CMV with no insert).
The corresponding immunoblot clearly shows the position o f these immunogenic
proteins as existing outside the 32-36 kDa range. Thus, these are not the 32, 34, or
36 kDa proteins initially pursued in this study.
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Fig 4. Coomassie brilliant blue-stained SDS-polyacrylamide gel (12.5%
acrylamide) o f selected clones. Lane 1, molecular mass standards in kilodaltons; lane
2, B. bacilliformis whole-cell lysate showing total protein profile; lane 3, total
protein profile o f pBK/CMV phagemid with no insert; lane 4, protein profile of
pLCl; lane 5, total protein profile of pLC4. Marked band (<) in lane 4 corresponds
to 39 kDa protein encoded by recovered DNA insert.
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D. Analysis of nucleotide sequences in the insert of pLCl
Figure 5 shows the map o f the sequenced insert which contains 3 complete
genes, 4 intergenic spacers (ITS), and part o f a fourth gene. Orientation of the genes
was surmised from homologues identified by BLAST. Thus, the 5' end contains
roughly 168 bp corresponding to a gene (rpsB) with homology to the 30S ribosomal
protein S2 o f Mesorhizobium loti. The first uninterrupted gene lies 122 bp
downstream from the S2 gene, and has 76% identity with the elongation fector-Ts
gene from Bartonella quintana (tsf). This gene is by fer the largest in the insert,
measuring almost a full kilobase in size (942 bp). The B. bacilliformis ts f gene was
found to have a 42.0 mol% G+C. The third gene is located 142 bp downstream of
ts f and is 720 bp long. This gene shares 64% identity with the uridylate kinase
{pyrH) gene o f M loti, and has a 39.1 mol% G+C. The final gene in this locus is
located 34 bp downstream frompyrH, and is 558 bp long with a 41.0 mol% G+C.
This gene (frr) encodes the ribosome recycling factor and shares homology with a B.
melitensis homologue (72% identity). Transmembrane computer predictions
(TMPred program; ISREC server) identified two potential transmembrane helices in
mature pyrH, found at amino acids 49 to 65 and 120 to 144. The immediate function
o f these helices is unknown, and the lack of a C-terminal phenylalanine would tend to
discourage a role as an integral outer membrane protein (51).
Analysis for inverted repeat sequences in the four intergenic spacers was
accomplished using PC/GENE software. Inverted repeats in these regions would be
characteristic o f potential Rho-independent transcriptional terminators. Non-
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palindromic repeats were found in three o f the four spacers, including IT Sl, ITS2,
and ITS4. The ITS3 spacer consisted o f only 34 bp, and had 2 palindromic repeats.
Analysis o f the ITS regions for potential promoter sequences by neural network
prediction yielded expected results. The 34 bp ITS3 contained no potential
promoters. ITS2, which seemed the most likely candidate for containing a promoter
region due to its relative position in the locus, had two hits. The second hit had a
score o f 0.99 by prokaryotic promoter neural network prediction due to the presence
o f a-TA TA AT region. Finally, ITSl had 3 hits. The importance o f these findings
will be discussed in the next chapter.

£ . Generation o f a deletion mutant in E.coli
Several attempts were made at generating a truncated form o f the insert by
deletional mutagenesis. Hindlll was used to cut at the internal restriction site lying
800 bp inside (see fig. 5). The 750-bp internal Hindlll fi'agment was excised fi'om
the gel, gene cleaned, religated, and transformed into DH5a cells. While no results
were generated, this experiment would have allowed us to map which o f the three
conç)lete genes on the insert encoded the gene product present as the 39-kDa band
in the total protein profile o f B. bacilliformis.

F. Nucleotide and predicted translation of sequence from insert
Figures 6, 8, and 10 contain the con^lete nucleotide sequence and translation
o f all three genes from the pLCl clone. These figures also display the nucleotide
sequence. In addition, the molecular weight o f each protein encoded by these genes
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was determined using Paul Stothard's home page
(http://www ualberta ca/-stothard/iavascript/dowTiload html)

Four-Gene Locus in Bartonella
bacilliformis

I

RM

Fig 5. (above) Map o f the rpsB-tsf-pyrH-frr locus in pLCl showing the relative
positions o f each gene, the intergenic spacers, and the Hindlll site located in ts f
(Following page) Map o f the pBK/CMV phagemid used in the excision of the insert.
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1

ATGAGCATTACTGCTGCACAAGTAAAAGAACTTCGAGAATTATCGGGCGCTGGTATGATG
M S I T A A Q V K E L R E L S G A G M M

60

61

GATTGCAAAGCAGCTCTAATGGAAACCAATGGTGATATAGAGACTGCGGTTGACTGGCTT
D C K A A L M E T N G D I E T A V D W L

120

1 2 1 CGCAAAAAAGGCATGGCCAAGGCAGATAAAAAGGCTGGACGTACAGCAGCTGAGGGATTA
R K K G M A K A D K K A G R T A A E G L

180

1 8 1 ATCGGTATTGCATCTAAAGGTTTAAGTGCTGTTGTGGTTGAAGTTAATTCTGAAACAGAT
I G I A S K G L S A V V V E V N S E T D

240

2 4 1 TTTGTTGCGCGCAACGATGCATTTCAAACAATTGTACGAAATGTGGCAACCGCTGCTTTA
F V A R N D A F Q T I V R N V A T A A L

300

3 0 1 GATACAGAAGGTAGCGTTGAATCTGTTTCTGCATCTATTTATCCAGGTTCTGAGAAAACA
D T E G S V E S V S A S I Y P G S E K T

360

3 6 1 GTAGAAGAAGCAATTAAGGATGCAATTGGTACAATTGGCGAGAATATGGCATTTCGTCGC
V E E A I K D A I G T I G E N M A F R R

420

4 2 1 TCAGCTAAGTTATCTGTTCAAAATGGTGCTGTTGCTACTTATATTCATAATAGTGTTGCT
S A K L 5 V Q N G A V A T Y 1 H N S V A

480

i
4 8 1 GATGGTCTTGGAAAGCTTGGAGTTTTAGTTGGTATTGAAACGACAGGAGATAAGGAAGTT
D G L G K L G V L V G I E T T G D K E V

540

5 4 1 GCGGTTGATTTTGCTCGCAAAGTTGCGATGCATATTGCTGCAACTAATCCATTAGCTTTA
A V D F A R K V A M H I A A T N P L A L

600

6 0 1 ACAGTAGCAGATGTTGATGCCAGTATTGTCGAGCGTGAAAAAGCAATTTTTTCAGATCAG
T V A D V D A S I V E R E K A I F S D Q

660

6 6 1 GCGCGTCAGTCAGGAAAGCCTGAAAATATTATTGAGAAGATGGTAGAAGGGCGCATACGT
A R Q S G K P E N I I E K M V E G R I R

720

7 2 1 AAATTCTACGAAGAGGTTGTTCTGCTTTCTCAGGCTTTTGTTATGAATCCTGATGTCACT
K F Y E E V V L L S Q A F V M N P D V T

780

7 8 1 GTTGAAGCTTCTTTGAAGGATGCAGAAAAAATGATTGGAGCTCCAGCAAAAATTACAGGT
V E A S L K D A E K M I G A P A K I T G

840

8 4 1 TTTGTTCGCTTTGCGTTGGGTGAAGGCGTAGAAAAGGAAGAGGTTGATTTTGCTGCAGAA
F V R F A L G E G V E K E E V D F A A E

900

9 0 1 G TTG CA G CTG CC G CA A A G G G Ttaatagttt t t t c g a t c a t t t a g c a g a a a t t t a a a a c t g
V A
A A A K G *
961 c a ttc ta a a ta a a a a a ta ta a tta tc tg a a g g g c a tc a c g tg a c a a tg tg g tg c c c tta g

960
1020

1 0 2 1 tg ta tc g a a a a c a a a a a g ta a tg tg c tc ttttg g a g a tta ta t

1064

Fig 6 Sequence o f ts f and its encoded protein. Nucleotides within the tsf ORF are indicated with
uppercase letters. The deduced amino acid sequence of tsf is shown below the first base o f its
respective codon triplet. The stop codon is indicated by an astwisk. Inverted repeats constituting a
potential p-independent terminator are underlined. The downward arrow indicates the position o f
the Hindlll site.
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1

ATGACATTAGCTCTTCGATATAAACGTGTTTTGTTAAAAGTATCTGGTGAAGCACTTATG
M T L A L R Y K R V L L K V S G E A L M

60

61

GGAGAACAAAGTTTTGGAATTGATGTTTCAGTTGCGGACCGTATTGCTTCTGATATTGCT
G E Q S F G I D V S V A D R I A S D I A

120

1 2 1 GAAGTGCGAAAAATGGGTGTGGAAGTCGCTATTGTAATAGGTGGTGGTAATATTTTTCGT
E V R K M G V E V A I V I G G G N I P R

180

1 8 1 GGGGTTGCTGTTGCTTCGCATGGTGGTGACCGTGTAACTGGTGATCATATGGGAATGCTT
G V A V A S H G G D R V T G D H M G M L

240

2 4 1 GCAACAGCTATCAATTCTCTGGCGTTGCGAACATCATTGACGAAGCTAGGTGTTGAAACG
A T A I N S L A L R T S L T K L G V E T

300

3 0 1 GTTGTACTCTCTGCAATTACCATGCCACAAATATGCGAAAGTTTTTCTCAGCGTAAGGCA
V V L S A I T M P Q I C E S F S Q R K A

360

3 6 1 ATGAGCTATATGAATCAAGGAAAAGTTGTTATTTTTGCAGGTGGTACAGGTAATCCATTT
M S 7 M N Q G R V V I F A 6 G T 6 N P F

420

4 2 1 TTTACTACTGATrCTGCTGCTACTTTACGAGCAGCAGAAATTGGTGCAGATGTTTTATTG
F T T D S A A T L R A A E I G A D V L L

480

4 8 1 AAAGGAACACAAGTAGACGGTATTTATTCTGCTGATCCAAAGATAAATTCTACCGCTAAA
K G T Q V D G I Y S A D P K I N S T A K

540

5 4 1 CGTTTTGATCAGCTAACGCATGTTGAAATTTTACGATTAGGATTGTCTATTATGGATACG
R F D Q L T H V E I L R L G L S I M D T

600

6 0 1 ACAGCAGTAACTTTAGCACGTGAAAATAACATACCGATTATTGTATATTCTATTCATGAA
T A V T L A R E N N I P I I V Y S I H E

660

6 6 1 AAAGGTGGTCTGACTAAGGTGTTAAATGGGACAGGGCGGTTTACAGTAGTATCGGAATGA
K G G L T K V L N G T G R F T V V S E C

720

7 2 1 AAA
K

723

Fig 8 Sequence o f pyrH and its encoded protein. Nucleotides within the pyrH ORF are indicated
with uppercase letters. The deduced amino acid sequence o f PyrH is shown below the first base of
its respective codon triplet. Amino acids in bold6ce indicate those identified by TMPred to be part
o f a transmembrane helix.
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1

ATGAGTGTTACATCAATTATGGATGATCTGAAACGTCGGATGGATGGTGCTATTTCAGCT
M S V T S I M D D L K R R M D G A I S A

60

61

TTTAAACACGAGTTAAGTGGTTTGCGGACTGGGCGAGCATCGGCGAGCTTGTTAGAGCCA
F K H E L S G L R T G R A S A S L L E P

120

1 2 1 TTGACTGTTGAGGCTTATGGTTCTGTTGTTCCTATAAAACAGGTTGCAAATATTTCTGTT
L T V E A Y G S V V P I K Q V A N I S V

180

1 8 1 CTAGAGCCACGGATGCTTTCAGTTTCTGTATGGGATAAAACGATGGTAGGAGCGGTGGAG
L E P R M L S V S V W D K T M V G A V E

240

2 4 1 CGCGCTATTCGTGATTGTGGTTTTGGTTTGAATCCCATTGTTGATGGTATGAATTTACGT

300

r

a

i

r

d

c

g

f

g

l

n

p

i

v

d

g

m

n

l

r

3 0 1 ATTCCTTTGCCTGAATTGAATGAAGAACGCCGTAAAGAATTGGTAAAAATCGCGCATCAA
I P L P E L N E E R R K E L V K I A H Q

360

3 6 1 TATGCAGAACAGGCTCGTGTTGCCATCCGCCATGTTCGTCGTGATGGTATGGATAATTTA
Y A E Q A R V A I R H V R R D G M D N L

420

4 2 1 AAAAAATTAGAAAAAGAAGGCGAAATTAGCCAAGATGAGGCTCGTAGTTTATCTGAAAAA

480

k

k

l

e

k

e

g

e

i

s

q

d

e

a

r

s

l

s

e

k

4 8 1 GTTCAAAAACTCACAGATGACGCCATTGCTGACATTGATAAAATTCTGATTATGAAAGAA
V Q K L T D D A I A D I D K I L I M K E

540

5 4 1 ACTGAAATTATGCAGGTT
T E I
M Q V

558

Fig 10 Sequence oîfrr and its encoded protein. Nucleotides within the frr ORF are indicated with
uppercase letters. The deduced amino acid sequence o f Frr is shown below the first base o f its
respective codon triplet.
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The EF-Ts gene {tsf) was shown to encode a protein o f molecular weight
32.4 kDa. The other two genes encoded protein products o f smaller molecular
weights. Uridylate kinase gene {pyrH) generated a protein product o f 25.4 kDa, and
the protein translated from the ribosome recycling fector gene (fir) was 20.8 kDa.
The elongation fector-Ts is actually a subunit o f the larger Elongation factor-T.
During the elongation phase o f translation, the EF-T combines with GTP to form the
EF-Tu-GTP complex. The EF-Ts subunit is subsequently released, leaving the EFTu-GTP complex to bind the aminoacyl-tRNA (47). Uridylate kinase functions
primarily as a nucleotide kinase. This enzyme is required for the generation o f UDP
from UMP. The ribosome recycling fector is instrumental in the fourth step o f
protein biosynthesis. The primary step in this post-termination disassembly centers
around the ribosome recycling factor. Simply, the ribosome recycling factor
catalyzes the disassembly of the post-termination complex. This conç>lex consists o f
the bound mRNA containing the termination codon, the deacylated tRNA bound to
the P-site, and the ribosome itself. In sum, the recycling o f ribosomes for another
round o f protein synthesis is accomplished (48). Figures 7, 9, and 11 are multiple
sequence alignments generated using Boxshade and Clustal showing the closest
homologues to these proteins in GenBank.
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Fig 7. Multiple sequence alignment of B. bacilliformis Tsf (ef-Ts) with B.
quintana Tsf and M loti T sf Identical amino acid residues are noted in black,
conserved residues in gray, and white indicates no homology. The GenBank
accession numbers for the B. quintana and M. loti homologues are Q9XCMS and
N P 102414, respectively.
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Fig 9. Multiple sequence alignment o f B. bacilliformis PyrH with M loti PyrH and
C crescentus PyrH. Identical amino acid residues are noted in black, conserved
residues in gray, and white indicates no homology. The GenBank accession numbers
for the M. loti and C. crescentus homologues are NP102410 and AAK23896,
respectively.
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Fig 11. Multiple sequence alignment of B. bacilliformis Frr with B. melitensis Frr
and M. loti Frr. Identical amino acid residues are noted in black, conserved residues
in gray, and white indicates no homology. The GenBank accession numbers for the
B. melitensis and M. loti homologues are ACCP94340 and NP 102409, respectively.
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Fig. 7 contains the amino acid sequence o f the protein product from the tsf
gene in B. bacilliformis^ and its homologues from B. quintana and Mesorhizobium
loti. B. quintana shares 76% amino acid identity with the TSF protein from B.
bacilliformis^ while there is 71% identity between M loti and B. bacilliformis
homologues. The amino acid sequence for PyrH and nearest homologues is given in
Fig. 8. Considerable identity (75%) was found to exist between B. bacilliformis and
the M loti homologue. The Caulobacter crescentus homologue also shared identity
with B. bacilliformis (54%). Figure 10 shows that the Frr protein in B. bacilliformis
has significant homology with Brucella melitensis (72%), and M. loti (65%).

G. Induction/expression of proteins encoded on the pLCl insert
An induction experiment involving E. coli strain XL-1 Blue harboring pLCl
(termed B111-10) was carried out as indicated in materials/methods. Cultures were
grown for 2, 3, and 4 hrs. respectively, and protein profiles from B. bacilliformis and
E, coli XL-1 Blue B111-10 at each time interval were separated on a 12.5% SDSPAGE gel. In addition, a negative control consisting o f E. coli containing the mother
phagemid (pBK/CMV) without DNA insert was included for comparison. Figures
11 and 12 clearly show a 39-kDa band in lanes 4-6 that is strongly produced when
the B111-10 strain is grown in the presence o f IPTG. This protein band is not
present in the mother phagemid, but is part o f the total protein profile for B.
bacilliformis (lanes 2). These results indicate that the 39-kDa protein is a product of
one o f the genes in the cloned insert o f pL C l.
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Figure 12 Coomassie brilliant blue-stained SDS-polyacrylamide gel (12.5%
acrylamide). Lane 1, molecular weight standards in kilodaltons; lane 2, B.
bacilliformis JB585 whole-cell lysate showing a total protein profile; lane 3, total
protein profile o f pBK/CMV phagemid; lanes 4-6, total protein profile o f pLCI after
induction with IPTG 2, 3 and 4 hours, respectively. Marked band indicates an insertspecific protein at approx. 39 kDa.
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Figure 13 Corresponding Western blot to Figure 12. Blotted proteins were probed
with anti-BLP antiserum. The 39 kDa bands in lanes 4-6 are clearly recognized by
the antibody, as are the 32, 34, and 36 kDa proteins in lane 2.
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Chapter IV
Discussion

Bartonella bacilliformis is an invasive, Gram negative intracellular parasite of
human erythrocytes and endothelial cells. While this bacterium has been traditionally
limited to a narrow range o f altitude in the Andes mountains, there are two dangers.
First, at least twelve species o f Bartonella are found worldwide. In addition, at least
one case o f Oroya fever has been recorded along the coastal regions o f Peru, far
removed from its endemic region (43). O f the twelve aforementioned species, five
pose a significant health threat to humans and are the cause o f a number o f emerging
diseases. Horizontal transfer o f virulence genes via transduction-mediated exchange
is one possible mechanism contributing to the rise in emergent infectious
bartonellosis.
While the initial purpose of this study was to characterize genes encoding the
32, 34, or 36-kDa BLP capsid proteins, genomic screening instead recovered a 2.8kbp DNA insert containing part of a locus o f genes encoding translational machinery
proteins o f the host bacterium. This locus consisted o f three complete genes, three
complete intergenic spacers, one inconqjlete gene, and part o f a fourth intergenic
spacer region. Multiple BLAST searches o f the sequenced DNA identified genes
with homology to elongation factor Ts from Bartonella quintana, 30S ribosomal
protein from Mesorhizobium loti, and both uridylate kinase and ribosome recycling
factor from Brucella melitensis.
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Based upon the many attempts at screening the same genomic library (~ a
dozen times), and the discovery o f a locus o f genes rather than the BLP capsid genes,
it is safe to theorize that the particular 32, 34, and 36 kDa proteins in question
cannot be recovered in a n f . coli XLOLR strain. One potential reason for this
problem could be that the recombinant capsid proteins are somehow toxic to E. coli,
thus preventing bacterial growth
The BLPs from B. bacilliformis were initially purified with the intent of
producing polyclonal antiserum to be used for screening genomic libraries. The
purification scheme, discussed earlier, was accomplished using a kan ^ strain, JB585.
This strain was chosen for two reasons. First, JB585 contains the neomycin
phosphotransferase gene. This is useful as it confers kanamycin resistance. In
addition, JB585 is also a fiagellin (ild^ strain, which prevents flagella contamination
during BLP preparation. Figure 2 clearly shows the presence of the 32, 34, and 36
kDa bands in lanes 2 and 3. These data suggest that these proteins are present in the
BLP and that the BLP exists in the B. bacilliformis lysate. The vaccine containing
purified BLPs was administered to the rabbit via the schedule shown in table 2.1. In
total, more than 25 ml o f antiserum were recovered over a 6-month span. Figure 3 is
a Western blot showing the specificity o f this antiserum and its reactivity to both a
purified preparation o f BLPs, and a total cell lysate o f B. bacilliformis. In addition
to being a cornerstone o f this project, the generated antisera will prove to be an
important research tool in future library screenings.
Multiple attençts were made at screening the XZAPII genomic library with
the polyclonal antisera generated above. Recovered plaque DNA was screened by
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initiai restriction digestion with Hind[\\^ and those with inserts retained. One clone
contained two fragments of roughly 5,800 bp and 1,900 bp. Thus, we concluded
from these data that since the pBK/CMV phagemid has a size of 4,512 bp, the
recovered clone (termed pLCl) consisted of the mother plasmid and a 2,800-bp
insert. Adding the approximate sizes o f the fragments yields a value o f 7,700 bp.
While this doesn’t exactly match the value of 4,512 bp, there is actually a third
fragment generated when pLCl is cut with HindiW. An analysis of the restriction
sites on the insert (http://www.uaIberta.ca/~stothard/javascript/rest_trans_map.html)
shows that in addition to the HindYW site at nucleotide 784 o f the insert, there is a
second site at nucleotide 1,076. Thus, a 300-bp fragment is being generated that is
not within resolution o f thel% agarose gel.
An SDS-PAGE gel/immunoblot o f pBK/CMV and pLCl screened with antiBLP antiserum is shown in Figure 4. There is at least one band at approximately 39
kDa which is recognized by the antibody. This band is also present in the total
protein profile for B. bacilliformis^ but is difficult to see on the accompanying
immunoblot (not shown). In addition, the band is not in the pBK/CMV control lane,
suggesting that it is insert-specific.
The insert o f pLCl was sequenced at the Murdock Molecular Biology facility
at the University o f Montana using the T3 and T7 promoters on the pBK/CMV
phagemid as initial primer with growing sequence used to walk the insert DNA.
Returned sequence was then converted to PASTA format, and BLAST searches
were accomplished using (http://www.ncbi-nlm.nih.gov/blast/Blast.cgil.
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The EF-Ts gene {tsj) was shown to encode a protein o f molecular weight 32.4 kDa.
The other two genes encoded protein products o f smaller molecular weights.
Uridylate kinase gene ipyrH) generated a protein product o f 25.4 kDa, and the
protein translated from the ribosome recycling fector gene {frr) was 20.8 kDa. The
elongation fector-Ts is actually a subunit of the larger Elongation fector-T. During
the elongation phase o f translation, the EF-T combines with GTP to form the EF-TuGTP con^lex (see Fig. 13). The EF-Ts subunit is subsequently released, leaving the
EF-Tu-GTP complex to bind the aminoacyl-tRNA (47).
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Figure 14 The interaction between EF-Ts and EF-Tu during translation.

Uridylate kinase functions primarily as a nucleotide kinase. This enzyme is
required for the generation of UDP from UMP. The ribosome recycling factor is
instrumental in the fourth step o f protein biosynthesis. The primary step in this post
termination disassembly centers around the ribosome recycling fector. Simply, the
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ribosome recycling fector catalyzes the disassembly o f the post-termination complex.
This complex consists o f the bound mRNA containing the termination codon, the
deacylated tRNA bound to the P-site, and the ribosome itself. In sum, the recycling
o f ribosomes for another round o f protein synthesis is accomplished (48).
The orientation o f the genes found on the locus (see Fig 5) for B.
bacilliformis appears to be unique. Four genes are present in the sequence, including
rpsB (encoding the 30S protein S2), ts f (EF-Ts), pyrH (UK), and fr r (RRF). Each of
these genes has an intergenic spacer o f variable length set between them. When
compared to the same gene cluster in other bacteria, there are some interesting
similarities. First, it has been shown that an evolutionarily conserved locus o f genes
exists in Lactococciis lactis (46), which consists ofpyrH (UK) and fr r (RRF). The
promoter for this cluster lies upstream o f an open reading frame (o rf\) o f unknown
function. The two genes lie downstream o f o r f ^ in the same orientation as they
appear in B. bacilliformis. Another common gene cluster that has been identified in
E. coli contains the rpsB gene and the ts f gene. A promoter that lies upstream of
rpsB serves both o f these genes. Again, the orientation o f this cluster is identical to
the four-gene cluster in B. bacilliformis. Since the two separate gene clusters just
discussed are evolutionarily highly conserved, it is safe to theorize that there is one
promoter for the pyrH!frr genes, and another for the rpsB and tsf genes. Another
possibility is that only one promoter exists for all four genes. Analysis o f the
nucleotide base sequence o f the insert in pLCl was accomplished using PC/GENE
software. The three intergenic spacer regions were entered, and the amount o f nonpalindromic repeats (nprs) was determined. Non-palindromic repeats are

40

characteristic o f rho-independent termination sequences. These sequences contain
multiple repeats that interact to form a secondary structure resembling a stem-loop.
It is theorized that RNA polymerase reaches this stem-loop and is slowed to the
point o f cessation (47). ITS 3, which was only 34 bp long, had no nprs. Thus, the
pyrH and fr r genes may be transcribed from the same promoter.
The ITS 1 region was analyzed for both non-palindromic repeats and
likelihood o f promoter regions. PC/GENE software determined that ITS 1 had six
nprs o f sizes 6-8 bp. In addition, there were three possible promoter predictions with
scores o f 0.94 or above by neural network prediction. The ITS 2 region, which lies
between ts f and pyrH, seemed to be the most logical place for a promoter region.
Both gene clusters in E. coli and L lactis terminated at some point downstream from
tsf, or upstream o f the pyrHlfrr genes. The cluster in E. coli contained only the rpsB
and ts f genes, while the L. lactis cluster had a separate promoter, controlling
transcription o f the pyrH and fr r genes. Regardless, I theorized that there should be
both a strong promoter for the pyrH and fr r genes in ITS 2. PC/GENE results
showed nine nprs in this region, characteristic o f some strong termination. Second,
there were two possible promoter sequences discerned. One had a relative score of
0.92, but the second region was much more impressive. This possible promoter had
a score o f 0.99, making ITS 2 the most likely place in all three intergenic regions
where a promoter was to be found. This 0.99 sequence contained the standard
TATA box about 75 bp upstream from the start ofpyrH. Thus, it is likely that there
are two separate promoters in this four-gene cluster from B. bacilliformis. An
unidentified promoter controls transcription o f the rpsB and ts f genes (as well as
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other genes upstream), and a second promoter in the ITS 2 region is responsible for
pyrH and frr.
From the data presented, it is not possible to accept this explanation
completely. Since we are dealing with computer-generated algorithms, and not
experimental data, the strength of the argument is tepid at best.
Translation and alignment with nearest relatives constitutes the brunt of
Figures 6-11. The fr r gene was shown to code for a protein o f 239 amino acids and
molecular weight o f 25.4 kDa. This protein had greatest similarity (77.6%) and
identity (72%) to B. melitensis. The pyrH gene encoded a protein o f 186 amino acids
and molecular weight o f 20.8 kDa, with greatest similarity (76%) and identity (64%)
with M. loti. For the ts f gene, a polypeptide containing 307 amino acids and having a
molecular weight o f 32.5 kDa was translated from the nucleotide sequence. The
most closely related protein was the Tsf foimd in B. quintana (84.6% similarity). Tsf
in B. bacilliformis had 260 matches out of a total 307 amino acids with B. quintana
(76% identity). This would most likely be the band that was visible at 39 kDa via
SDS-PAGE analysis. As stated earlier, attempts at deleting part o f the pLCl insert,
and re-introducing it into E. coli via transformation ended in M ure. Since this
deletion would have inactivated tsf, it would have proven beyond a doubt the relative
position o f the protein product o f tsf'm the protein profile.
The intensity of the insert-specific protein bands in the induction experiment
(Fig. 12) was strong, demonstrating that the genes on the insert were both in the
correct frame and direction relative to the lacZ gene. This result is important since it
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helps lis to visualize which bands on the SDS-PAGE gel/immunoblot are
representative o f the insert-specific genes.
In conclusion, the initial intent of this research was to identify and
characterize at least one o f the genes encoding the 32, 34, and 36 kDa BLP proteins
in B. bacilliformis. While we were unable to correctly locate the appropriate insert
fi'om genomic library screenings corresponding to these proteins we did, however,
identify a novel operon locus fi’om B. bacilliformis. The arrangement o f the genes,
rpsB-tsf-pyrH-frr, is similar to that reported in E.coli and P. aeruginosa (50). This
locus contained four genes essential for protein translation in the pathogen. Possible
future work may involve a more careful study o f the genes in the locus (Le. repeat
generation o f the deletion mutants-also chromosomal walking upstream o f the rpsB
gene) in order to better characterize the genes and their protein products. In
addition, over 25 ml o f polyclonal antiserum was generated against the purified
BLPs. This useful tool can be utilized for future attempts at locating an insert fi’om
the genomic library that may contain the genes initially sought after.
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